Assenagon Asset Management S.A. Nektar Therapeutics Transaction History

Assenagon Asset Management S.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$0.49 - $0.96 $381,693 - $747,808	-778,967 Reduced 31.58%	1,687,300 $1.57 Million
Q4 2023 Jan 17, 2024	SELL	$0.42 - $0.57 $155,062 - $210,441	-369,196 Reduced 13.02%	2,466,267 $1.38 Million
Q3 2023 Nov 06, 2023	BUY	$0.51 - $1.05 $385,021 - $792,692	754,945 Added 36.29%	2,835,463 $1.7 Million
Q2 2023 Jul 25, 2023	BUY	$0.53 - $1.03 $751,019 - $1.46 Million	1,417,018 Added 213.57%	2,080,518 $1.21 Million
Q1 2023 Apr 18, 2023	BUY	$0.64 - $3.15 $233,108 - $1.15 Million	364,232 Added 121.71%	663,500 $464,000
Q2 2022 Jul 27, 2022	BUY	$3.17 - $6.17 $904,718 - $1.76 Million	285,400 Added 2057.98%	299,268 $1.14 Million
Q4 2021 Feb 01, 2022	BUY	$10.83 - $18.41 $150,190 - $255,309	13,868 New	13,868 $187,000
Q4 2020 Feb 01, 2021	SELL	$15.77 - $19.03 $3.1 Million - $3.74 Million	-196,449 Closed	0 $0
Q3 2020 Oct 07, 2020	BUY	$16.59 - $24.79 $3.26 Million - $4.87 Million	196,449 New	196,449 $3.26 Million
Q2 2019 Aug 12, 2019	SELL	$31.0 - $36.3 $2.71 Million - $3.18 Million	-87,503 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$31.58 - $46.35 $619,883 - $909,804	-19,629 Reduced 18.32%	87,503 $2.94 Million
Q4 2018 Jan 23, 2019	BUY	$30.43 - $56.65 $3.26 Million - $6.07 Million	107,132 New	107,132 $3.52 Million

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.